These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3897449)

  • 1. The coloscreen self-test for detection of fecal occult blood.
    Rodney WM; Ruggiero C
    J Fam Pract; 1985 Sep; 21(3):200-4. PubMed ID: 3897449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does use of the Coloscreen Self-Test improve patient compliance with fecal occult blood screening?
    Park SI; Saxe JC; Weesner RE
    Am J Gastroenterol; 1993 Sep; 88(9):1391-4. PubMed ID: 8362837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for colorectal cancer. A comparison of 3 fecal occult blood tests.
    Levin B; Hess K; Johnson C
    Arch Intern Med; 1997 May; 157(9):970-6. PubMed ID: 9140267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of fecal occult blood tests for early detection of gastrointestinal pathology.
    Stelling HP; Maimon HN; Smith RA; Haddy RI; Markert RJ
    Arch Intern Med; 1990 May; 150(5):1001-5. PubMed ID: 2331181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colocare self-test versus Hemoccult II Sensa for fecal occult blood testing.
    Foliente RL; Wise GR; Collen MJ; Abdulian JD; Chen YK
    Am J Gastroenterol; 1995 Dec; 90(12):2160-3. PubMed ID: 8540507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
    Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
    Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal occult blood testing: clinical value and limitations.
    Simon JB
    Gastroenterologist; 1998 Mar; 6(1):66-78. PubMed ID: 9531118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of fecal occult blood tests for detection of gastrointestinal bleeding in pediatric patients.
    Rosenthal P; Jennings MT
    Am J Gastroenterol; 1992 Nov; 87(11):1575-9. PubMed ID: 1442676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal occult blood testing for colorectal cancer screening: use the finger.
    Burke CA; Tadikonda L; Machicao V
    Am J Gastroenterol; 2001 Nov; 96(11):3175-7. PubMed ID: 11721767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter prospective study of immunochemical fecal occult blood testing for colorectal cancer detection.
    Lohsiriwat V; Thavichaigarn P; Awapittaya B
    J Med Assoc Thai; 2007 Nov; 90(11):2291-5. PubMed ID: 18181309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors that influence the decision to do an adequate evaluation of a patient with a positive stool for occult blood.
    Shields HM; Weiner MS; Henry DR; Lloyd JA; Ransil BJ; Lamphier DA; Gallagher DW; Antonioli DA; Rosner BA
    Am J Gastroenterol; 2001 Jan; 96(1):196-203. PubMed ID: 11197252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physicians' reminders promote annual fecal occult blood testing compliance].
    Vinker S; Shumla V; Kitai E
    Harefuah; 2000 Jun; 138(12):1019-21, 1088, 1087. PubMed ID: 10979422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study.
    Li S; Nie Z; Li N; Li J; Zhang P; Yang Z; Mu S; Du Y; Hu J; Yuan S; Qu H; Zhang T; Wang S; Dong E; Qi D
    Chin Med J (Engl); 2003 Feb; 116(2):200-2. PubMed ID: 12775229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing.
    Stokamer CL; Tenner CT; Chaudhuri J; Vazquez E; Bini EJ
    J Gen Intern Med; 2005 Mar; 20(3):278-82. PubMed ID: 15836533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study evaluating two alternate methods of stool collection for the fecal occult blood test.
    Greenwald B
    Medsurg Nurs; 2006 Apr; 15(2):89-94. PubMed ID: 16700247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of upper gastrointestinal blood with fecal occult blood tests.
    Rockey DC; Auslander A; Greenberg PD
    Am J Gastroenterol; 1999 Feb; 94(2):344-50. PubMed ID: 10022627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation into the effects of oral iron supplementation on in vivo Hemoccult stool testing.
    Anderson GD; Yuellig TR; Krone RE
    Am J Gastroenterol; 1990 May; 85(5):558-61. PubMed ID: 2186616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy.
    Greenberg PD; Bertario L; Gnauck R; Kronborg O; Hardcastle JD; Epstein MS; Sadowski D; Sudduth R; Zuckerman GR; Rockey DC
    Am J Gastroenterol; 2000 May; 95(5):1331-8. PubMed ID: 10811348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.